US Broker Ratings

Becton, Dickinson and Company (BDX) Stock Analysis: Exploring a 11.21% Potential Upside

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, stands as a prominent player in the medical instruments and supplies industry. With a market capitalization of $53.61..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Evaluating a Leader in Clinical Research with a Noteworthy 89% ROE

Medpace Holdings, Inc. (NASDAQ: MEDP) is a significant player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Cincinnati, Ohio, Medpace provides a comprehensive suite of..

The Cooper Companies, Inc. (COO) Stock Report: Analyzing a 23.91% Potential Upside for Investors

The Cooper Companies, Inc. (NYSE: COO), a prominent player in the healthcare sector with a focus on medical instruments and supplies, presents an intriguing opportunity for investors. With a market..

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a 41.84% Potential Upside for Investors

Align Technology, Inc. (NASDAQ: ALGN), a prominent player in the healthcare sector, is known for its innovative solutions in the medical instruments and supplies industry. With a market capitalization of..

Danaher Corporation (DHR) Stock Analysis: Uncovering a 25.94% Upside Potential in Healthcare Innovation

Danaher Corporation (NYSE: DHR), a titan in the healthcare diagnostics and research sector, commands the attention of investors with its robust market capitalization of $138.41 billion. This US-based company, known..

Fresenius Medical Care AG (FMS): Investor Outlook on a Global Leader with 19.22% Upside Potential

Fresenius Medical Care AG (NYSE: FMS), a powerhouse in the healthcare sector, stands at the forefront of providing dialysis and related services worldwide. With a market capitalization of $14.96 billion,..

The Cigna Group (CI) Stock Analysis: A 27% Upside Potential on the Horizon

The Cigna Group (NYSE: CI) stands as a formidable player in the healthcare sector, particularly within the healthcare plans industry. With a market capitalization of $77.51 billion, Cigna is a..

Glaukos Corporation (GKOS) Stock Analysis: Exploring a 46.71% Upside Potential in the Medical Devices Sector

Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector, specifically within the medical devices industry, offers a compelling investment opportunity. With a market capitalization of $4.79 billion, Glaukos..

DaVita Inc. (DVA) Stock Analysis: A 17.93% Upside Potential Amidst Steady Healthcare Growth

DaVita Inc. (NYSE: DVA), a leader in the healthcare sector specializing in kidney dialysis services, offers a compelling investment opportunity with a potential upside of 17.93%. Headquartered in Denver, Colorado,..

Grifols, S.A. (GRFS) Stock Analysis: Unpacking a 25% Potential Upside in the Healthcare Sector

Grifols, S.A. (NASDAQ: GRFS), a prominent player in the healthcare sector, is capturing investor attention with its robust 25.10% potential upside, as indicated by its average target price of $12.19...

Exact Sciences Corporation (EXAS) Stock Analysis: 20% Potential Upside Captures Investor Attention

Exact Sciences Corporation (NASDAQ: EXAS), a prominent player in the healthcare sector, specializes in diagnostics and research with a focus on innovative cancer screening and diagnostic tests. With a current..

Centene Corporation (CNC) Investor Outlook: Navigating Healthcare with a 6.82% Potential Upside

Centene Corporation (NYSE: CNC), a stalwart in the healthcare sector, presents a nuanced opportunity for investors navigating the complex healthcare plans industry. With a market capitalization of $15.6 billion, Centene..

Regencell Bioscience Holdings L (RGC) Investor Outlook: A Hong Kong Biotech’s Rollercoaster Year with a 52-Week Range from $0.09 to $78.00

Regencell Bioscience Holdings Limited (NASDAQ: RGC) stands out in the healthcare sector, specifically within the drug manufacturers specializing in Traditional Chinese Medicine (TCM). Headquartered in Causeway Bay, Hong Kong, this..

Tempus AI, Inc. (TEM) Stock Analysis: Balancing Growth with Valuation Challenges in the Health Information Sector

Tempus AI, Inc. (TEM), a notable player in the health information services industry, is capturing investor attention with its robust expansion in the healthcare technology sector. With a market capitalization..

HealthEquity, Inc. (HQY) Stock Analysis: A 30% Upside Potential Beckons Investors

HealthEquity, Inc. (NASDAQ: HQY) is carving out a significant niche within the healthcare sector, specifically in the health information services industry. With a market capitalization of $8.08 billion, the company..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Strong Buy Ratings Point to a Promising 15.85% Upside

As a prominent player in the healthcare sector, Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is making notable strides with its innovative contributions to the drug manufacturing industry, focusing on specialty and..

Walgreens Boots Alliance (WBA): Investor Outlook with 8.35% Dividend Yield and Strategic Global Footprint

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) stands as a notable player in the healthcare sector, specifically within the pharmaceutical retail industry. With its roots dating back to 1909, this Deerfield,..

Charles River Laboratories (CRL) Stock Analysis: Navigating Potential 14.38% Upside in the Healthcare Sector

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a pivotal player in the healthcare sector, particularly in the diagnostics and research industry. With a current market capitalization of $7.65..

Avantor, Inc. (AVTR): Investor Outlook Reveals Potential Upside and Strategic Positioning in Healthcare

Avantor, Inc. (NYSE: AVTR), a prominent player in the Healthcare sector, stands at a pivotal juncture, drawing attention from investors eager to explore its potential upside. With a market capitalization..

AbbVie Inc. (ABBV): Investor Outlook with a Robust 112.85% Return on Equity and Solid Dividend Yield

AbbVie Inc. (NYSE: ABBV), a titan in the healthcare sector, continues to captivate investor attention with its impressive financial metrics and strong product portfolio. As a key player in the..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds